chr11-2848935-A-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000218.3(KCNQ1):​c.*932A>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.391 in 453,978 control chromosomes in the GnomAD database, including 38,200 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.39 ( 12221 hom., cov: 34)
Exomes 𝑓: 0.39 ( 25979 hom. )

Consequence

KCNQ1
NM_000218.3 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -2.06

Publications

27 publications found
Variant links:
Genes affected
KCNQ1 (HGNC:6294): (potassium voltage-gated channel subfamily Q member 1) This gene encodes a voltage-gated potassium channel required for repolarization phase of the cardiac action potential. This protein can form heteromultimers with two other potassium channel proteins, KCNE1 and KCNE3. Mutations in this gene are associated with hereditary long QT syndrome 1 (also known as Romano-Ward syndrome), Jervell and Lange-Nielsen syndrome, and familial atrial fibrillation. This gene exhibits tissue-specific imprinting, with preferential expression from the maternal allele in some tissues, and biallelic expression in others. This gene is located in a region of chromosome 11 amongst other imprinted genes that are associated with Beckwith-Wiedemann syndrome (BWS), and itself has been shown to be disrupted by chromosomal rearrangements in patients with BWS. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Aug 2011]
KCNQ1-AS1 (HGNC:42790): (KCNQ1 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 11-2848935-A-G is Benign according to our data. Variant chr11-2848935-A-G is described in ClinVar as [Benign]. Clinvar id is 304268.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.838 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KCNQ1NM_000218.3 linkc.*932A>G 3_prime_UTR_variant Exon 16 of 16 ENST00000155840.12 NP_000209.2 P51787-1Q96AI9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KCNQ1ENST00000155840.12 linkc.*932A>G 3_prime_UTR_variant Exon 16 of 16 1 NM_000218.3 ENSP00000155840.2 P51787-1

Frequencies

GnomAD3 genomes
AF:
0.386
AC:
58641
AN:
152064
Hom.:
12212
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.405
Gnomad AMI
AF:
0.331
Gnomad AMR
AF:
0.473
Gnomad ASJ
AF:
0.385
Gnomad EAS
AF:
0.859
Gnomad SAS
AF:
0.493
Gnomad FIN
AF:
0.372
Gnomad MID
AF:
0.440
Gnomad NFE
AF:
0.312
Gnomad OTH
AF:
0.403
GnomAD2 exomes
AF:
0.445
AC:
58052
AN:
130500
AF XY:
0.440
show subpopulations
Gnomad AFR exome
AF:
0.414
Gnomad AMR exome
AF:
0.553
Gnomad ASJ exome
AF:
0.378
Gnomad EAS exome
AF:
0.872
Gnomad FIN exome
AF:
0.368
Gnomad NFE exome
AF:
0.313
Gnomad OTH exome
AF:
0.397
GnomAD4 exome
AF:
0.394
AC:
118970
AN:
301796
Hom.:
25979
Cov.:
0
AF XY:
0.400
AC XY:
68735
AN XY:
171996
show subpopulations
African (AFR)
AF:
0.409
AC:
3496
AN:
8554
American (AMR)
AF:
0.552
AC:
15051
AN:
27274
Ashkenazi Jewish (ASJ)
AF:
0.381
AC:
4109
AN:
10786
East Asian (EAS)
AF:
0.870
AC:
8009
AN:
9210
South Asian (SAS)
AF:
0.478
AC:
28516
AN:
59650
European-Finnish (FIN)
AF:
0.367
AC:
4541
AN:
12368
Middle Eastern (MID)
AF:
0.390
AC:
449
AN:
1150
European-Non Finnish (NFE)
AF:
0.311
AC:
49407
AN:
158762
Other (OTH)
AF:
0.384
AC:
5392
AN:
14042
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
6758
13516
20273
27031
33789
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
454
908
1362
1816
2270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.386
AC:
58693
AN:
152182
Hom.:
12221
Cov.:
34
AF XY:
0.394
AC XY:
29304
AN XY:
74404
show subpopulations
African (AFR)
AF:
0.405
AC:
16826
AN:
41498
American (AMR)
AF:
0.473
AC:
7239
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.385
AC:
1335
AN:
3466
East Asian (EAS)
AF:
0.859
AC:
4440
AN:
5170
South Asian (SAS)
AF:
0.492
AC:
2376
AN:
4830
European-Finnish (FIN)
AF:
0.372
AC:
3940
AN:
10592
Middle Eastern (MID)
AF:
0.449
AC:
132
AN:
294
European-Non Finnish (NFE)
AF:
0.312
AC:
21248
AN:
68016
Other (OTH)
AF:
0.404
AC:
855
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1837
3674
5511
7348
9185
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
550
1100
1650
2200
2750
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.346
Hom.:
16930
Bravo
AF:
0.396
Asia WGS
AF:
0.632
AC:
2193
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

May 12, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 27531917, 22199116) -

Long QT syndrome 1 Benign:1
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. -

Atrial fibrillation, familial, 3 Benign:1
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. -

Jervell and Lange-Nielsen syndrome 1 Benign:1
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. -

Short QT syndrome type 2 Benign:1
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. -

Congenital long QT syndrome Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Long QT syndrome Benign:1
Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
0.51
DANN
Benign
0.70
PhyloP100
-2.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10798; hg19: chr11-2870165; API